About 40 million express texts for covid will be produced annually by the Imbian Lab company, localized in the special economic zone of Moscow and the science city Koltsovo in the Novosibirsk region. The development of the enterprise allows to detect the coronavirus antigen in human saliva, this is the first such domestic test. This was announced by the head of the department of investment and industrial policy of Moscow Vladislav Ovchinsky.
“Timely primary diagnosis is the key to an effective fight against the spread of infectious diseases. The company strives to make the diagnostic process as simple and fast as possible. The company’s capacities allow to produce about 40 million rapid tests annually. In October 2022, the products were launched into mass production, the first batch amounted to 20 thousand pieces. In the near future, the set will appear in pharmacies,” Ovchinsky added.
The Imbian Lab test can detect SARS-CoV-2 virus antigen through a saliva sample rather than through a nasal swab. The result is available within 7-10 minutes. The test has a high diagnostic sensitivity, which will allow you to quickly identify even asymptomatic patients. As specified in the city government, the innovation will meet the need for domestic diagnostic systems.
“We strive to develop the most convenient test systems and improve the accuracy of results. This is very important for making the correct diagnosis and prescribing the necessary therapy. Our system recognizes all known strains of coronavirus, including Alpha, Omicron and Stealth. When new strains appear, additional clinical trials will be carried out,” said the CEO of Imbian Lab. Veronika Osipova.
Imbian Lab began localizing production at the Alabushevo site in 2022. The area of the future enterprise will be about 2.5 thousand square meters. This area will house production sites, laboratories and office space. Another production site with an area of about two thousand square meters is located in the Novosibirsk region.
“The company is systematically increasing its product portfolio. To date, 75 registration certificates have been received for the production of medical test systems for the diagnosis of various diseases. Comfortable working conditions in the special economic zone of Moscow will contribute to the development of new prototypes,” emphasized the Director General of the Technopolis Moscow SEZ Gennady Degtev.